Bayer : Q2 due 4 Aug – CropScience strength to compensate for Pharma weakness
>Expect supportive Q1 trends continuing in Q2 at CropScience - We expect the favourable market environment with an even slightly upgraded US corn acreage outlook to 89.9m acres from 89.5m acres shown in prospective plantings before, only slight sequential decline in spot glyphosate prices witnessed in China as a reference and a sequentially firming US$ vs € to shape Q2 2022 reporting in Crop Science. We project Crop Science to report 22% y-o-y sales growth to € 6,149m...Bayer is a life sciences group based in Germany. Co.'s operations are organized along three divisions: Pharmaceuticals (engaged in prescription pharmaceuticals for cardiology and women's healthcare); Consumer Health (engaged in non-prescription products in dermatology, dietary supplement, analgesic, gastrointestinal, allergy, cold and flu, foot care, sun protection and cardiovascular risk prevention categories); and CropScience (engaged in the development of seeds and plant traits; crop protection; and for gardens, the green industry and non-agricultural pest control). Co. also maintains an Animal Health business unit engaged in the development of products for farm and companion animals.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.